BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10071128)

  • 1. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation.
    Stacchini A; Aragno M; Vallario A; Alfarano A; Circosta P; Gottardi D; Faldella A; Rege-Cambrin G; Thunberg U; Nilsson K; Caligaris-Cappio F
    Leuk Res; 1999 Feb; 23(2):127-36. PubMed ID: 10071128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.
    Rasul E; Salamon D; Nagy N; Leveau B; Banati F; Szenthe K; Koroknai A; Minarovits J; Klein G; Klein E
    PLoS One; 2014; 9(8):e106008. PubMed ID: 25162594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
    Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
    Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Realgar induces apoptosis in the chronic lymphocytic leukemia cell line MEC‑1.
    Liu X; Li X; Wang L; Lv X; Chen N; Li P; Lu K; Wang X
    Mol Med Rep; 2013 Dec; 8(6):1866-70. PubMed ID: 24141727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
    Rassenti LZ; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of central nervous system in prolymphocytoid transformation of chronic lymphocytic leukemia.
    Kuwabara H; Kanamori H; Takasaki H; Takabayashi M; Yamaji S; Tomita N; Fujimaki K; Fujisawa S; Ishigatsubo Y
    Leuk Lymphoma; 2003 Jul; 44(7):1235-7. PubMed ID: 12916878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro.
    Panayiotidis P; Ganeshaguru K; Jabbar SA; Hoffbrand AV
    Br J Haematol; 1993 Nov; 85(3):439-45. PubMed ID: 8136263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.
    Dancescu M; Rubio-Trujillo M; Biron G; Bron D; Delespesse G; Sarfati M
    J Exp Med; 1992 Nov; 176(5):1319-26. PubMed ID: 1402678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia.
    Pers JO; Berthou C; Porakishvili N; Burdjanadze M; Le Calvez G; Abgrall JF; Lydyard PM; Youinou P; Jamin C
    Leukemia; 2002 Jan; 16(1):44-52. PubMed ID: 11840262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells.
    Voltan R; di Iasio MG; Bosco R; Valeri N; Pekarski Y; Tiribelli M; Secchiero P; Zauli G
    Clin Cancer Res; 2011 Sep; 17(17):5649-55. PubMed ID: 21753157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement.
    Melo JV; Foroni L; Brito-Babapulle V; Luzzatto L; Catovsky D
    Clin Exp Immunol; 1988 Jul; 73(1):23-8. PubMed ID: 3262465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface phenotype and adhesion activity of B-cell chronic lymphoid leukemias.
    Takeuchi H; Katayama I
    Leuk Lymphoma; 1993 Jun; 10(3):209-16. PubMed ID: 8220119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
    Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
    Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 and bax expression and chlorambucil-induced apoptosis in the T-cells and leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients.
    Thomas A; Pepper C; Hoy T; Bentley P
    Leuk Res; 2000 Oct; 24(10):813-21. PubMed ID: 10996199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis.
    Gottardi D; Alfarano A; De Leo AM; Stacchini A; Aragno M; Rigo A; Veneri D; Zanotti R; Pizzolo G; Caligaris-Cappio F
    Br J Haematol; 1996 Sep; 94(4):612-8. PubMed ID: 8826882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.
    Schettino EW; Cerutti A; Chiorazzi N; Casali P
    J Immunol; 1998 Jan; 160(2):820-30. PubMed ID: 9551917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53.
    Christodoulopoulos G; Fotouhi N; Krajewski S; Reed JC; Alaoui-Jamali M; Panasci L
    Cancer Lett; 1997 Dec; 121(1):59-67. PubMed ID: 9459175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.